- Home
- About
- 🤖 AskAnzal AI Advisor
- 📅 Book a Call
- Your Account
- My AskAnzal Account
Over 2,000 real rulings — analysed for what they mean to your team. Published every day.
Showing 1914 cases
Five Novartis-funded Entresto promotional articles on the BJC website linked to prescribing info but omitted the adverse event reporting statement in the…
Complaint alleged off-label promotion and public advertising because Ocrevus PI appeared on a congress hub page mentioning oncology and COVID-19. PMCPA ruled…
Pfizer’s UK website press release about Paxlovid used a dark grey (not black) ▼ symbol. Panel ruled breach of Clause 5.1 (high…
Astellas alleged Janssen’s Erleada nurse support service (package deal) induced prescribing. The Panel found Astellas did not evidence wrongdoing and ruled no…
Pulse ad for Trixeo linked COPD exacerbations and death with a “Take action with Trixeo” call-to-action, creating an unsubstantiated and misleading implication…
A senior UK Pfizer employee retweeted a US colleague’s tweet claiming 95% efficacy for a COVID-19 vaccine candidate before UK authorisation, with…
A Trelegy promotional video summarising an ERS 2022 symposium overstated statistical significance in NMA comparisons on COPD exacerbations, leading to breaches for…
Novo Nordisk failed to disclose some transfers of value on time and did not disclose others at all due to HCO misclassification.…
A third-party LinkedIn post named four AstraZeneca oncology POMs. UK-based AstraZeneca employees ‘liked’ it, which the Panel said disseminated promotional content to…
PMCPA case AUTH/3728/1/23: complaint alleging promotion of Zeposia (ozanimod hydrochloride) against Bristol Myers Squibb. Outcome: no breach; matter not within the scope…
Acepiro (acetylcysteine) banner ad on a learned society homepage lacked the required adverse event reporting statement within the ad itself. Linking to…
Complaint alleged a patient organisation guideline was promotional for Nilemdo/Nustendi and lacked contraindication detail, PI and certification. Panel found Daiichi Sankyo not…
Complaint alleged Sun Pharma phone numbers and website were not functional, potentially affecting patient queries and side effect reporting. Panel found one…
Organon’s Nexplanon ad on a closed doctors’ network was alleged to omit key contraindications and cancer-risk context. Panel found the ad and…
Complaint alleged a senior employee’s LinkedIn ‘Experience’ section promoted Enhertu to the public and off-label, using terms like “blockbuster” and “new”. Panel…
Anzal, our PMCPA rulings expert, has knowledge of over 2,000 published cases — ask about precedents, clauses, and how they apply to your situation.
One real case. One key lesson. Every week — free.